secwatch.observer — SEC 8-K summary
======================================

Issuer:     LABCORP HOLDINGS INC. (LH)
CIK:        0000920148
Form:       8-K
Filed at:   2023-09-11T23:59:59+00:00
Accession:  0000920148-23-000068
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Labcorp EVP Kirchgraber resigns, receives $2.75M severance and equity acceleration
--------------------------------------------------------------------------------

- Paul Kirchgraber, Sr. Advisor to CEO and former head of Drug Development, resigned effective Sept 1, 2023.
- Severance payment of $2,748,997 (2x salary plus average bonus) plus $20,600 medical stipend, $3,000 outplacement.
- Equity: RSUs/options vesting within 12 months vest on separation; performance awards continue prorated.
- Departure treated as 'good reason' under Labcorp's Severance Plan; includes non-compete/non-solicit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/920148/000092014823000068/0000920148-23-000068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/920148/000092014823000068/lh-20230908.htm
  HTML page:      https://secwatch.observer/filing/0000920148-23-000068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer